GRAY MICHAEL has filed 6 insider transactions across 2 companies since January 2023.
Most recent transaction: a sale of 852 shares of Upstream Bio, Inc. ($UPB) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Upstream Bio, Inc. | $UPB | GRAY MICHAEL | CFO and COO | S | Common Stock | 852 | $9.29 | 29,648.0000 | 54,038,591 | 2.79% | 0.00% |
| Jan. 2, 2026 | Upstream Bio, Inc. | $UPB | GRAY MICHAEL | CFO and COO | A | Common Stock | 30500 | $0.00 | 30,500.0000 | 54,038,591 | 9999.99% | 0.06% |
| Jan. 2, 2026 | Upstream Bio, Inc. | $UPB | GRAY MICHAEL | CFO and COO | A | Stock Option (Right to Buy) | 91500 | $0.00 | 91,500.0000 | 54,038,591 | 9999.99% | 0.17% |
| Feb. 6, 2025 | Upstream Bio, Inc. | $UPB | GRAY MICHAEL | CFO and COO | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2023 | Enliven Therapeutics, Inc. | $ELVN | GRAY MICHAEL | CFO & COO | S | Common Stock | 9856 | $4.67 | 27,610.0000 | 0 | 26.31% | 0.00% |
| Jan. 30, 2023 | Enliven Therapeutics, Inc. | $ELVN | GRAY MICHAEL | CFO & COO | S | Common Stock | 3596 | $3.92 | 37,466.0000 | 0 | 8.76% | 0.00% |